Dabur Pharma gains on Fresenius investment
Shares of Dabur Pharma extended gains after German healthcare group Fresenius said its unit will invest 10-30 million euros over the next 2-3 years to double Dabur Pharma's API plant capacity.
By ET Online |
MUMBAI: Shares of Dabur Pharma extended gains after German healthcare group Fresenius said its unit will invest 10-30 million euros over the next 2-3 years to double Dabur Pharma's API plant capacity.
At 1 pm, the Dabur Pharma share was up 2.73 per cent at Rs 64 with volume traded at 11,529 against two-week average of 11,950 shares.
At 1 pm, the Dabur Pharma share was up 2.73 per cent at Rs 64 with volume traded at 11,529 against two-week average of 11,950 shares.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
